Pharmacological spinal cord protection with magnesium during replacement of the thoracic and thoracoabdominal aorta [2]

Annals of Thoracic Surgery

Volumn 72, Issue 6, 2001, Pages 2180-2181

  Lang Lazdunski, Loïc ^a   Bachet, Jean ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DEXTRORPHAN; MAGNESIUM SULFATE; MEMANTINE; RILUZOLE;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; AORTA SURGERY; BLOOD BRAIN BARRIER; ISCHEMIA; LETTER; MAGNESIUM BLOOD LEVEL; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL CORD ISCHEMIA;

EID: 0035665816     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4975(01)02919-8     Document Type: Letter

References (5)

1. Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia; updated in 2001
2. Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole
3. Memantine for prevention of spinal cord injury in a rabbit model
4. 2+ protect against irreversible damage during CNS ischemia
5. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus